KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Revenue (2016 - 2025)

Zimmer Biomet Holdings has reported Revenue over the past 17 years, most recently at $2.2 billion for Q4 2025.

  • Quarterly results put Revenue at $2.2 billion for Q4 2025, up 10.9% from a year ago — trailing twelve months through Dec 2025 was $8.2 billion (up 7.2% YoY), and the annual figure for FY2025 was $8.2 billion, up 7.2%.
  • Revenue for Q4 2025 was $2.2 billion at Zimmer Biomet Holdings, up from $2.0 billion in the prior quarter.
  • Over the last five years, Revenue for ZBH hit a ceiling of $2.2 billion in Q4 2025 and a floor of $1.6 billion in Q1 2021.
  • Median Revenue over the past 5 years was $1.8 billion (2022), compared with a mean of $1.9 billion.
  • Peak annual rise in Revenue hit 43.81% in 2021, while the deepest fall reached 14.77% in 2021.
  • Zimmer Biomet Holdings' Revenue stood at $1.8 billion in 2021, then increased by 2.7% to $1.8 billion in 2022, then grew by 6.3% to $1.9 billion in 2023, then grew by 4.28% to $2.0 billion in 2024, then grew by 10.9% to $2.2 billion in 2025.
  • The last three reported values for Revenue were $2.2 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.1 billion (Q2 2025) per Business Quant data.